Washington, D.C., July 11, 2017 -- FOR IMMEDIATE RELEASE:
|
||||||
July 11, 2017
Patient-Friendly Clinical Trials Finder Gives Access to Clinical Trials in Real-Time
Revolutionary new tool matches patients with personalized results in latest research
July 11th, Washington, DC– Clinical trials are the key to new cancer treatments. However, less than 3% of cancer patients participate in these types of studies. In the case of colorectal cancer, the number is less than half of that.
The new online Clinical Trial Finder is one of the only databases with direct backend access to all trials posted on ClinicalTrials.gov as well as the National Cancer Institute, ensuring that new trials and the latest research are being added to the Clinical Trial Finder in real time.
“Finding a clinical trial can be confusing, to say the least. When you’re going through something as hard as cancer, the last thing you want to do is try to sort through all the various names and phases of trials,” says Michael Sapienza, President & CEO of Colon Cancer Alliance.
With the new Finder, patients are able to get personalized results based on location, biomarker, phase, stage and more. In addition, patients can choose to email their doctor or the Colon Cancer Alliance’s Patient/Family Support team all within the Finder portal.
“With advances in tumor testing, it is now easier than ever to carefully select a trial that may benefit you based on your tumor's genetic makeup. Thanks to a clinical trial, I went from an inoperable, scared, dying stage 4 colon cancer patient to being cancer free,” Stephen Estrada, colorectal cancer survivor.
Clinical trials are the hope for the future of cancer research. To learn more about the Clinical Trial Finder, visit https://www.ccalliance.org/clinical-trials
The Colon Cancer Alliance’s Clinical Trial Finder is generously supported by Boston Biomedical, Genentech, Taiho Oncology and Smart Patients.
###
About the Colon Cancer Alliance
The Colon Cancer Alliance is a national nonprofit committed to ending colon cancer within our lifetime. Working with our nation of passionate advocates, we are empowered to support the needs of patients and survivors, eager to raise awareness of preventative screening, and poised to help fund critical research. We are fiercely determined to end colon cancer once and for all. www.ccalliance.org
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/a3976224-734f-42dc-9fc7-75c9b0f9e3c5
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/ed68723e-1330-4240-955d-807d2924e3c0
Sara Geist Colon Cancer Alliance 202-766-6046 [email protected]


MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Apple Turns 50: From Garage Startup to AI Crossroads
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 



